Mesothelioma Trials: Fentanyl Sublingual Spray

Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.

If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.

The Phoenix, Arizona based pharmaceutical company InSys Therapeutics, Inc. is currently seeking patients diagnosed with mesothelioma and other forms of cancer to participate in a clinical study of Fentanyl Sublingual Spray.

This purpose of the Phase III randomized study is to determine the drug’s effectiveness in treating breakthrough cancer pain in patients already receiving opioid class drugs to treat their pain.

At the present time, the study is only being conducted in Phoenix, Arizona. For more information, contact the study chair, Ellen Feigal, M.D. at InSys Therapeutics.

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease. If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.